The use of psychedelics in end-of-life care allows individuals to disassociate and alleviate fears surrounding dying, but must be used in the context of an adult brain and not individuals under the age of 25. The speaker also questions the scenario of being open to hearing what her dad said if it were not for her obligation to write a book.